Top 10 Tech Companies To Own For 2014

DELAFIELD, Wis. (Stockpickr) -- There isn't a day that goes by on Wall Street when certain stocks trading for $10 a share or less don't experience massive spikes higher. Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.

>>5 Big Trades to Conquer a Correcting Market

Just take a look at some of the big movers in the under-$10 complex from Thursday, including American Apparel (APP), which soared higher by 21%; Everyware Global (EVRY), which ripped to the upside by 17%; Telik (TELK), which jumped higher by 9.7%; and Samson Oil & Gas (SSN), which trended up 9.4%. You don't even have to catch the entire move in lower-priced stocks such as these to make outsized returns when trading.

One low-priced biotechnology stock that recently ripped to the upside was Prana Biotechnology (PRAN), which I highlighted in June 26's "5 Stocks Under $10 Setting Up to Soar" at around $2.15 a share. I mentioned in that piece that shares of Prana Biotechnology recently formed a double bottom chart pattern at $1.90 to $2 a share right above its 50-day moving average. This stock was just starting to spike higher right above those support levels and it was beginning to move within range of triggering a major breakout trade above some key overhead resistance levels at $2.22 to $2.35 a share.

Top 10 Casino Stocks To Own Right Now: Concur Technologies Inc.(CNQR)

Concur Technologies, Inc. provides integrated travel and expense management solutions for companies of various industries, sizes, and geographies. It offers the Concur Connect platform, a cloud computing software solution primarily on a subscription basis, which enables customers, partners, suppliers, and third-party developers to connect. The company provides various solutions to streamline the travel procurement, itinerary management, expense management, and invoice management processes. Its solutions include online travel procurement solutions, which automate corporate travel booking and processing; itinerary management solutions that enable individual business travelers and their organizations to manage and share travel itinerary information; and automated expense management solutions, which simplify the expense reporting process. The company also offers other value-added and extended services that leverage its integrated cloud offerings, including expense reimbursemen t; expense report auditing services to streamline the process of managing and substantiating expense receipts; business intelligence that enable customers to use captured data to analyze trends, influence budget decisions, improve forecasting, and monitor for fraudulent activity; and invoice management solutions to automate, simplify, and reduce the costs associated with the process of entering, approving, and managing the payment of vendor invoices. In addition, it provides consulting; and various extended services, such as site administration, audit and compliance services, advanced analytics, and customized integration in connection with its integrated travel and expense management solutions. Concur markets and sells its solutions worldwide through direct sales organizations; and indirect distribution channels, such as strategic resellers and referral partners, as well as through its Website. The company was founded in 1993 and is headquartered in Redmond, Washington.

Advisors' Opinion:

• [By Matt Jarzemsky]

  Salesforce is up 33% year-to-date. Workday Inc.(WDAY) has rallied 38% and expense-accounting software provider Concur Technologies(CNQR) is up 44%, to name a few.

Top 10 Tech Companies To Own For 2014: MedAssets Inc.(MDAS)

MedAssets, Inc. provides technology enabled products and services for hospitals, health systems, and other non-acute healthcare providers in the United States. It operates in two segments, Spend and Clinical Resource Management, and Revenue Cycle Management. The Spend and Clinical Resource Management offers a suite of cost management services, supply chain analytics, and data capabilities; medical device and clinical resource consulting, which includes implantable physician preference items, utilization management, and service line consulting; supply chain outsourcing and procurement services; capital equipment lifecycle management; lean process and workforce optimization solutions; process improvement consulting; business intelligence tools; and performance analytics and data management tools, such as service line analytics, spend analytics and strategic information services, e-commerce, client master item file services, electronic contract portfolio catalog, and decision support services. The Revenue Cycle Management segment provides a suite of products and services spanning the revenue cycle workflow from patient access and financial responsibility; case management, coding, and documentation; charge capture and revenue integrity; strategic pricing; claims processing; denials management and reimbursement integrity; revenue cycle and supply chain integration; revenue recovery and accounts receivable management; and outsourced services. It delivers technology-enabled solutions primarily through the company-hosted software, software-as-a-service, or Web-based applications. As of December 31, 2011, the company served approximately 4,200 acute care hospitals and 100,000 ancillary or non-acute provider locations. MedAssets, Inc. was incorporated in 1999 and is headquartered in Alpharetta, Georgia.

Advisors' Opinion:

• [By Javier Hasse, Insider Monkey]

  Fundamentally, ADT looks appealing. Its stock trades at 16.5 times the company�� earnings, versus an industry average of 29.4x, while it boasts industry leading margins and above average returns on equity and assets. However, above-average debt levels are concerning, so its financial standing must be further analyzed.

  MedAssets (MDAS)

  The second company in this list is MedAssets (MDAS), a $1.37 billion market cap provider of technology-enabled products and services.

Top 10 Tech Companies To Own For 2014: Fluidigm Corporation(FLDM)

Fluidigm Corporation engages in the development, manufacture, and marketing of microfluidic systems for growth markets in the life science and agricultural biotechnology (Ag-Bio) industries. The company?s proprietary microfluidic systems consist of instruments and consumables, including chips (integrated fluidic circuits) and reagents. Its technology enables customers to perform and measure various biochemical reactions on samples smaller than the content of a single cell by utilizing minute volumes of reagents and samples; and rapid preparation of multiple samples in parallel for next generation DNA sequencing. The company?s products include the BioMark HD system, which performs high-throughput gene expression analysis using real-time and end point PCR, SNP genotyping, single-cell analysis, and digital PCR using TaqMan, EvaGreen dye, and other chemistries; The EP1 System that performs end point PCR and is commonly used in production settings for Ag-Bio, digital PCR, and copy number variation experiments using TaqMan, EvaGreen dye, and other chemistries; and the Access Array system that enables automated sample preparation and tagging for next generation DNA sequencers. The company serves pharmaceutical and biotechnology companies, academic institutions, diagnostic laboratories, and Ag-Bio companies. Fluidigm Corporation distributes its instruments and supplies through direct field sales and support organizations in North America, Europe, and Japan; and through distributors or sales agents in parts of Europe, Latin America, the Middle East, and the Asia-Pacific region. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.

Advisors' Opinion:

• [By Seth Jayson]

  Fluidigm (Nasdaq: FLDM  ) reported earnings on May 1. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q1), Fluidigm beat slightly on revenues and exceeded expectations on earnings per share.

Top 10 Tech Companies To Own For 2014: Sapient Corporation(SAPE)

Sapient Corporation helps clients to leverage marketing and technology to transform their businesses in the United States and internationally. It operates in three segments: SapientNitro, Sapient Global Markets, and Sapient Government Services. The SapientNitro segment offers Web and interactive development, traditional advertising, media planning and buying, strategic planning and marketing analytics, and multi-channel commerce strategy and solutions, including a focus on mobile, and content and asset management strategies and solutions. This segment also provides integrated marketing and creative services, such as visual concept, design, and implementation through multiple media; brand building and direct response programs, audience segmentation, and profiling strategies; customer loyalty strategies; customer relationship strategy and implementation; customer lead generation and management; and integrated advertising campaigns. The Sapient Global Markets segment offers i ntegrated advisory, program management, analytics, technology, and operations services to capital and commodity markets. This segment also provides business and information technology strategy, process and system design, program management, custom development and package implementation, systems integration, and outsourced services to financial services and energy services markets. The Sapient Government Services segment offers digital marketing strategy and execution, program management, solution delivery, strategy, and communications and outreach services, as well as provides consulting, technology, and marketing services to the United States governmental agencies and non-governmental organizations. The company serves financial services, technology and communications, consumer, travel, automotive, energy services, government, health, and education sectors. Sapient Corporation was founded in 1990 and is headquartered in Boston, Massachusetts.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Sapient (Nasdaq: SAPE  ) , whose recent revenue and earnings are plotted below.

• [By CRWE]

  Sapient (NASDAQ:SAPE) reportedthat Alan J. Herrick, president and chief executive officer, and Joseph S. Tibbetts, Jr., senior vice president and chief financial officer, will present at the Sanford C. Bernstein Strategic Decisions Conference at The Waldorf Astoria in New York on Thursday, May 31, 2012 from 4:00 p.m. to 4:45 p.m. ET.

Top 10 Tech Companies To Own For 2014: Shenandoah Telecommunications Co(SHEN)

Shenandoah Telecommunications Company, a diversified telecommunications company, provides regulated and unregulated telecommunications services to end-user customers and other communications providers in the southeastern United States. It offers a suite of voice, video, and data communications services; and sells telecommunications equipment. The company?s Wireless segment provides digital wireless service to a portion of a four-state area covering the region from Harrisburg, York, and Altoona, Pennsylvania to Harrisonburg, Virginia. It owns 149 towers and leases tower space to other wireless communications providers in Virginia, West Virginia, Maryland, and Pennsylvania. This segment also offers personal communications services through a digital wireless telephone and data network. Its Wireline segment provides regulated and unregulated telephone services and leases fiber optic facilities primarily in the northern Shenandoah Valley. This segment also offers information s ervices and Internet access to customers in the northern Shenandoah Valley and surrounding areas. In addition, it is involved in the resale of long distance service for calls placed to locations outside the regulated telephone service area by telephone customers. As of December 31, 2011, this segment had approximately 1,410 dial-up customers and 12,351 digital subscriber line customers, as well as served approximately 10,483 long distance customers. The company?s Cable Television segment provides coaxial cable-based television service in the portions of Shenandoah County, Virginia, as well as in communities in West Virginia, southern and southwestern Virginia, and western Maryland. It had approximately 137,238 cable revenue generating units. The company was founded in 1902 and is headquartered in Edinburg, Virginia.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Leading and Lagging Sectors
  Wednesday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Horizon Pharma (NASDAQ: HZNP) and Pernix Therapeutics Holdings (NASDAQ: PTX). In trading on Wednesday, telecommunications services shares were relative laggards, down on the day by about 0.39 percent. Top decliners in the sector included Shenandoah Telecommunications Co (NASDAQ: SHEN), off 3.3 percent, and CalAmp (NASDAQ: CAMP), down around 2.4 percent.

Top 10 Tech Companies To Own For 2014: Vonage Holdings Corp.(VG)

Vonage Holdings Corp. provides broadband communication services in the United States, Canada, and the United Kingdom. The company offers voice and messaging services through session initiation protocol (SIP) based voice over Internet protocol network. The company?s primary product offering is Vonage World, a residential plan with unlimited calling domestically and to approximately 60 countries, including India, Mexico, and China for a flat monthly rate. It also provides broadband telephone replacement services to residential, small office, and home office customers through various service plans with a range of basic features, including call waiting, caller ID with name, call forwarding, and voicemail. In addition, the company offers mobile services through mobile applications that can be downloaded for iPhone, iPad, iPod touch, and Android OS devices. Further, the company provides Vonage Mobile, a free downloadable mobile application that provides free calling and messagi ng between users who have the application, as well as traditional paid international calling to any other phone. It markets its services through in-bound telemarketing and online direct sales, as well as through regional and national retailers. As of December 31, 2011, the company had approximately 2.4 million subscriber lines. Vonage Holdings Corp. was incorporated in 2000 and is headquartered in Holmdel, New Jersey.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Vonage Holdings (NYSE: VG) was down as well, dropping 6.06 percent to $3.48 despite seemingly little news.

  Canadian Solar (NASDAQ: CSIQ) was down, falling 12.20 percent to $22.23 after the company reported weaker-than-expected Q1 earnings and issued a weak forecast.

• [By Jake L'Ecuyer]

  Equities Trading UP
  Vonage Holdings (NYSE: VG) was up early on in Thursday's session, gaining 15.74 percent to $3.53 after news broke that the company would acquire Vocalocity for $130 million.

Top 10 Tech Companies To Own For 2014: Provectus Pharmaceuticals Inc (PVCT)

Provectus Pharmaceuticals, Inc., incorporated on May 1, 1978, is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10. The Company has transferred all its intellectual property related to over the counter (OTC) products and non-core technologies to its subsidiaries and designated, such subsidiaries as non-core to its primary business of developing its oncology and dermatology prescription drug candidates. The Company focuses on developing its prescription drug candidates PV-10 and PH-10. The Company is developing PV-10 for treatment of several life threatening cancers, including metastatic melanoma, liver cancer, and breast cancer. The Company is developing PH-10 to provide minimally invasive treatment of chronic severe skin afflictions such as psoriasis and atopic dermatitis, a type of eczema. All of the Company's prescription drug candidates are in either the pre-clinical or clinical trial stage.

PV-10

As of December 31, 2011, the Company is developing PV-10, a sterile injectible form of rose bengal disodium (Rose Bengal), for direct injection into tumors. Its PV-10 is retained in diseased or damaged tissue but dissipates from healthy tissue. The Company had conducted Phase I and Phase IIstudies of PV-10 for the treatment of metastatic melanoma, and Phase I studies of PV-10 for the treatment of liver and breast cancers.

PH-10

The Company�� prescription drug candidate PH-10 is an aqueous hydrogel formulation of Rose Bengal for topical administration to the skin. The Company is developing PH-10 for the treatment of cutaneous skin disorders, specifically psoriasis and atopic dermatitis. In August 2011, the Company completed follow-up of all Phase IIc patients.

Over-the-Counter Pharmaceuticals

The Company had desi! gnated its subsidiary that holds its OTC products, GloveAid and Pure-ific, Pure-Stick, Pure N Clear as non-core. The Company�� GloveAid is a hand cream with both antiperspirant and antibacterial properties, for the comfort of users��hands during and after the wearing of disposable gloves. Its Pure-ific line of products includes two quick-drying sprays, Pure-ific and Pure-ific Kids, that immediately kill up to 99.9% of germs on skin and prevent regrowth for six hours. Pure-ific products prevent the spread of germs and thus complement its other OTC products designed to treat irritated skin or skin conditions, such as acne, eczema, dandruff and fungal infections. Its Pure-ific sprays have been designed with convenience in mind and are targeted towards mothers, travelers, and anyone concerned about the spread of sickness-causing germs.

The Company�� acne products Pure-Stick and Pure N Clear work by decreasing the production of fats, oils and sweat that create an environment conducive to unchecked growth of bacteria. Secondly, the products also act to reduce the number bacteria already present. The Pure-Stick and Pure N Clear are applied topically to affected areas there are no safety concerns with healthy skin.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Provectus Biopharmaceuticals (NYSE: PVCT) was also down, falling 3.02 percent to $3.01, letting out some air after the company's opening on the NYSE Friday.

• [By Luke Jacobi]

  Provectus Biopharmaceuticals (NYSE: PVCT) was also down, falling 3.38 percent to $3.01, letting out some air after the company's opening on the NYSE Friday.